| MOQ: | 1000 |
| Price: | $6 |
| Standard Packaging: | gift box |
| Delivery Period: | 35 working days |
| Payment Method: | T/T |
| Supply Capacity: | 100000 |
| Study | Participants | Dosage/Duration | Primary Outcomes |
|---|---|---|---|
| Keio University Safety Study (2020) | 10 healthy men | 100-500 mg single dose | Safe; no vital sign changes |
| Prediabetic Women Metabolism Trial (2022) | 10 women (55-79 yrs) | 250 mg/day, 10 weeks | ↑ Insulin sensitivity, ↓ BP |
| Dose-Dependent Middle-Aged Adults (2022) | 80 adults (40-65 yrs) | 300-900 mg/day, 60 days | Safe; ↑ NAD+, ↑ Health scores |
| Arterial Function Trial (2023) | 62 adults (45-75 yrs) | 300 mg/day, 12 weeks | ↑ Vascular function |
| Liposomal NMN Comparison (2025) | 15 men (>40 yrs) | 350 mg/day, 4 weeks | Liposomal ↑ NAD+ more |